Health care stocks were steady premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently.
TScan Therapeutics (TCRX) shares rose past 19% after the company said it signed a securities purchase agreement with Lynx1 Capital Management and an investment fund advised by Lynx1 for the sale of about $30 million of pre-funded warrants.
OS Therapies (OSTX) said Tuesday that it signed securities purchase agreements with investors to sell 1.5 million units at $4 each for gross proceeds of $6 million. OS Therapies shares were up over 3% premarket.
MultiPlan (MPLN) shares fell by 7%, offsetting a portion of Tuesday's nearly 95% increase that followed the company's announcement of a refinancing to extend its debt maturities.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。